Zusammenfassung
Die Panarteriitis nodosa wurde von Kussmaul und Maier 1866 beschrieben und damals Periarteriitis nodosa genannt aufgrund der vielen kleinen Knötchen, die entlang einer muskulären Arterie zu finden sind. Als man die wahre Natur der Knötchen erkannte, wurde die Krankheit in Pan- oder Polyarteriitis nodosa (PAN) umbenannt. Es handelt sich um eine nekrotisierende Arteriitis, die kleine und mittelgroße Arterien der meisten Organe befallen kann. Typischerweise sind die Nieren und Viszeralarterien betroffen. Bei der klassischen PAN sind die Pulmonalarterien nicht mitbetroffen, Bronchialgefäße können aber beteiligt sein.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Al Dhanhani A, Macaulay R, Maloney B, Hanly JG (2006) Meningeal involvement in Wegener’s granulomatois. J Rheumatol 33:364–367
Antoniu SA (2007) Treatment options for refractory Wegener’s granulomatosis: a role for rituximab? Curr Opin Investig Drugs 8(11):927–932
Ashton-Key MR, Gallagher PJ (1992) False-negative temporal artery biopsy. Am J Surg Pathol 16:634–635
Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249
Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol:1810–1817
Burke AP, Virmani R (2001) Review: localized vasculitis. Semin Diagn Pathol 18:59–66
Cotch MF et al (1996) The epidemiology of Wegener’s granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution form population-based data sources. Arthritis Rheum 39:87–92
Evans JM, O’Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 122:502–507
Feiner HD, Raghavendra BN, Phelps R, Rooney L (1984) Inflammatory abdominal aortic aneurysm. Report of six cases. Hum Pathol 15:454–459
Gilmour JR (1941) Giant-cell chronic arteriitis. J Pathol 53:263–277
Glück T, Straub RH, Schölmerich J, Lang B (1997) Infections and vasculitis. Z Rheumatol 56(3):105–113
Guillevin L, Lhote F (1995) Distinguishing polyarteriitis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 7(1):20–24
Guillevin L et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430
Hellmann DB (2004) Low-dose aspirin in the treatment of giant cell arteritis. Arthritis Rheum 50:1026–1027
Hoffman GS et al (1992) Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498
Hoffman GS et al (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46:1309–1318
Homme JL, Aubry M-C, Tazelaar HD et al (2006) Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30:1159–1168
Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357:2153–2165
Joseph FG, Lammie GA, Scolding NJ (2007) CNS lupus: a study of 41 patients. Neurology 69:644–654
Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:106–114
Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, Matsumoto Y, Kawakami K, Kasashima F, Moriya M, Kimura K, Ohtake H, Nakanuma Y (2008) Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 32:197–204
Klein RG, Hunder GG, Stanson AW, Sheps SG (1975) Large artery involvement in giant cell (temporal) arteriitis. Ann Intern Med 83:806–812
Korte MR, van Heerde MJ, de Man RA, Betjes MH (2008) Rituximab for the treatment of glomerulonephritis in hepatitis C associated cryoglobulinaemia. Neth J Med 66(1):27–30
Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98(2):97–111
Lee MS, Smith SD, Galor A, Hoffman GS (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54:3306–3309
Lie JT (1995) Aortic and extracranial large vessel giant cell arteriitis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 24:422–431
Mahr A, Girard T, Agher R, Guillevin L (2005) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s Granulomatosis and prospective follow-up. Rheumatology 40:492–498
Miklossy J, Kunther T, Bogouslavsky J, Regli F, Janzer RC (1990) Meningovascular form of neuroborreliosis: similarities between neuropathological findings in a case of Lyme disease and those occurring in tertiary neurosyphilis. Acta Neuropathol 80:568–572
Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry M-C, Tazelaar HD (2006) Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30:1150–1158
Nesher G, Nesher R (2008) Giant cell arteritis and polymyalgia rheumatica, Chapter 24. In: Ball GV, Bridges SL Jr (Hrsg) Vasculitis. Oxford University Press, Oxford
Olin JW, Shih A (2006) Thromboangiitis obliterans (Buerger’s disease). Curr Opin Rheumatol 18:18–24
Pipitone N, Salvarani C (2008) Improving therapeutic options for patients with giant cell arteriitis. Curr Opin Rheumatol 20:17–22
Reinhold-Keller E, Beuge N, Latza U, DeGroot K, Rudert H, Nolle B, Heller M, Gross W (2000) An interdisciplinary approach to the care of patients with Wegener’s granulomatosis. Long-term outcome in 155 patients. Arthritis Rheum 43:1021–1032
Reinhold-Keller E et al (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53:93–99
Rose AG, Dent DM (2006) Inflammatory variant of abdominal atherosclerotic aneurysm. Arch Pathol Lab Med 105:409–413 (1980)
Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, Iwasaki H, Kojima M (2008) IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 32:553–559
Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteriitis. N Engl J Med 347(4):261–271
Salvarani C, Brown RD Jr, Calamia KT, Christianson TJ, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG (2007) Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol 62:442–451. Comment in: Ann Neurol 62:430–432
Saulsbury FT (2007) Clinical update: Henoch-Schönlein purpura. Lancet 369:976–978
Schaublin GA, Michet CJ, Dyck PJ, Burns TM (2005) An update on the classification and treatment of vasculitic neuropathy. Lancet Neurol 4:853–865
Schmidt WA (2006) Takayasu and temporal arteriitis. Front Neurol Neurosci 21:96–104
Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteriitis. Rheumatology (Oxford) 47(1):96–101
Scott TF, Vandora K, Valeri A, Chieffe C, Schramke C (2007) Aggressive therapy for neurosarcoidosis: long-term follow up of 48 treated patients. Arch Neurol 64:691–696
Segelmark M, Selga D (2007) The challenge of managing patients with polyarteriitis nodosa. Curr Opin Rheumatol 19(1):33–38
Simon RW, Fritz T, Amann-Vesti BR, Romer GS, Fischer B, Kagi MK (2005) An unusual presentation of giant cell arteriitis. Vasa 34(2):128–130
Siva A, Altintas A, Sapi S (2004) Behçet’s syndrome and the nervous system. Curr Opin Neurol 17:347–357
Starosta MA, Brandwein SR (2007) Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 68:1079–1080
Steere AC (2001) Lyme disease. N Engl J Med 345:115–125
Tato F, Hoffmann U (2006) Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44:176–182
Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS (2007) Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience. Medicine (Baltimore) 86:269–277
Warrington KJ, Matteson EL (2007) Management guidelines and outcome measures in giant cell arteriitis (GCA). Clin Exp Rheumatol 25(Suppl 47):137–141
Weidner N (2001) Giant-cell vasculitides. Sem. Diagn Pathol 18:24–33
Wiszniewska M, Devuyst G, Bogousslavsky J (2007) Giant cell arteriitis as a cause of first-ever stroke. Cerebrovasc Dis 24:226–230
Woude FJ van der, Rasmussen N, Lobatto S, et al (1985) Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1:425–429
Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B, Czarnacki M, Doskocz R, Kowal-Gierczak B (2000) Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Angiology 51:141–150
Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management and advances in treatment. Nat Clin Pract Rheumatol 3:148–155
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Amann-Vesti, B., Fontana, A., Kuhlencordt, P., Müller, J.G. (2020). Vaskulitiden: Spezielle Krankheitsbilder. In: Debus, E., Gross-Fengels, W. (eds) Operative und interventionelle Gefäßmedizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53380-2_118
Download citation
DOI: https://doi.org/10.1007/978-3-662-53380-2_118
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-53378-9
Online ISBN: 978-3-662-53380-2
eBook Packages: Medicine (German Language)